Citalopram Tablet
Product Images NDC 50090-5172

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Citalopram (NDC 50090-5172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (D78873c1 29ce 478b Aa3d D1a11a2750ce 01)

Chemical structure of citalopram hydrobromide depicting its molecular components including aromatic rings, fluorine, and nitrogen groups, as seen in the provided diagram.*

FDA Label Image

Image (D78873c1 29ce 478b Aa3d D1a11a2750ce 02)

A data table showing drug-placebo differences in the number of cases of suicidality per 1000 patients treated with Citalopram, separated by age ranges. It lists additional or fewer cases compared to placebo for age groups <18, 18-24, 25-64, and ≥65.*

FDA Label Image

Image (D78873c1 29ce 478b Aa3d D1a11a2750ce 03)

A data table titled 'Treatment-Emergent Adverse Events: Incidence in Placebo-Controlled Clinical Trials' showing percentage of patients reporting various adverse events for Citalopram (N=1063) versus placebo (N=446). Events are categorized by body system including autonomic, nervous, gastrointestinal, general, musculoskeletal, psychiatric, respiratory, and urogenital systems, with specific percentages for each adverse event in both groups.*

FDA Label Image

Image (D78873c1 29ce 478b Aa3d D1a11a2750ce 04)

A data table titled 'Adverse Events Associated With Discontinuation of Treatment in Short-Term, Placebo-Controlled, Depression Trials.' It compares the percentage of patients discontinuing due to adverse events between Citalopram (N=1063) and placebo (N=446) across various body system/adverse events, including general, gastrointestinal, central nervous system, and psychiatric disorders.*

FDA Label Image

Label Image (Lbl500905172)

Citalopram 20 mg oral tablets packaging label from A-S Medication Solutions. The label includes the product name, strength, quantity of 30 tablets, storage instructions to keep at 68 to 77 degrees Fahrenheit, and manufacturer information. The label displays the product NDC 50090-5172 and advises to see the dosage page insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.